Why is "Acute radiation syndrome" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-06 21:10:34
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Acute radiation syndrome (ARS), also known as radiation sickness or radiation poisoning, is a collection of health effects that are caused by being exposed to high amounts of ionizing radiation in a short period of time. Symptoms can start within an hour of exposure, and can last for several months. Early symptoms are usually nausea, vomiting and loss of appetite. In the following hours or weeks, initial symptoms may appear to improve, before the development of additional symptoms, after which either recovery or death follows.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
U.S.-funded Tivic study targets deadly gut damage after radiation - Stock Titan
-
Gastrointestinal acute radiation syndrome: current knowledge and perspectives - Nature
-
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome - ACCESS Newswire
-
Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS]) - PR Newswire
-
Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers - Yahoo Finance
-
Tivic CEO To Present at Emerging Growth Virtual Conference - San Antonio Today - National Today
-
Exceptional Use Recommendation for Nuclear Emergency Drug - Medscape
-
NSRI, NU awarded $24.5M contract to develop acute radiation syndrome prophylactic - Nebraska Today
-
ReAlta Development of RLS-0071 as Acute Radiation Syndrome Medical Countermeasure - Global Biodefense
-
What are nuclear contamination risks after Israel's attack on Iran's nuclear facilities - WION
-
FDA Grants Orphan Drug Designation for Acute Radiation Syndrome Drug - Cure Today
-
▶️ The ATX-Files - 9-1-1: Lone Star: The Crew Treat A Victim With Acute Radiation Syndrome - IMDb
-
Treating the long-term effects of acute radiation syndrome | NanoMed Project | Results in Brief | H2020 - CORDIS
-
European Medicines Agency CHMP Recommends EU Approval of Partner Therapeutics IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Haematopoietic Sub-syndrome of Acute Radiation Syndrome) - PR Newswire
-
FDA outlines Acute Radiation Syndrome drug development expectations under its Animal Rule - AgencyIQ by POLITICO
-
FDA Approves Sargramostim for Hematopoeic Acute Radiation Syndrome - Oncology Nursing News
-
Gastrointestinal Acute Radiation Syndrome: Insights and Outlook - Bioengineer.org
-
Treatment Granted Orphan Drug Status for Acute Radiation Syndrome - Medical Professionals Reference
-
A pandemic waiting to happen: Acute radiation syndrome and the immediate need for nuclear countermeasures - drugdiscoverytrends.com
-
Integrative network analyses of transcriptomics data reveal potential drug targets for acute radiation syndrome - Nature
-
AIMP3 Deletion Induces Acute Radiation Syndrome-like Phenotype in Mice - Nature
-
Emergency Department: Evaluation and Management of Affected Patients - Centers for Disease Control and Prevention | CDC (.gov)
-
Neulasta Approved for Treatment of Acute Radiation Syndrome - Global Biodefense
-
Identifying radiation responsive exon-regions of genes often used for biodosimetry and acute radiation syndrome prediction - Nature
-
CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice - Nature
-
RNCP selects Redhill's opaganib for evaluation for acute radiation syndrome - BioWorld News
-
Studies Suggest Stockpiles of Stem Cells from Fat Could Treat Acute Radiation Syndrome in Mass Populations - Genetic Engineering and Biotechnology News
-
NeoImmuneTech begins trial of primates for acute radiation syndrome - koreabiomed.com
-
How Rx100 works to combat acute radiation syndrome - Knoxville News Sentinel
-
NeoImmuneTech bags orphan drug tag for IL-7 acute radiation syndrome treatment - Pharmaceutical Technology
-
Orphan Drug Designation Granted to Myelo001 for Treatment of Acute Radiation Syndrome - HCPLive
-
Acute radiation syndrome: On the issues of triage, stem cell sources and immunosuppressive therapy | Newswise - Newswise
-
Resources for Clinicians | Radiation Emergencies - Centers for Disease Control and Prevention | CDC (.gov)
-
Examples of the Acute Radiation Syndrome in Man - NEJM
-
The Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome - Nature
-
Minimizing the consequences of nuclear accidents through effective communication - Bulletin of the Atomic Scientists
-
Research Team Awarded $2.4 Million for Radiation Treatment Study - UTHSC News
-
NIH’s NIAID Initiating Dose Evaluation Studies in Animal Models of Pluristem’s PLX-R18 in the Treatment of Acute Radiation Syndrome - BioInformant
-
FDA Grants Pluristem Orphan Drug Designation for Its PLX-R18 Cell Therapy as Treatment for Acute Radiation Syndrome - BioInformant
-
Medical management of the acute radiation syndrome | López | Reports of Practical Oncology and Radiotherapy - Via Medica Journals
-
Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning - Pharmaceutical Technology
-
Humanetics Presents BIO 300 Radiation Countermeasure Data at DoD Scientific Meeting - Global Biodefense
-
Major Player in the Acute Radiation Syndrome Market Analysis - openPR.com
-
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine® (sargramostim) for the Treatment of Acute Radiation Syndrome - PR Newswire
-
How Rx100 works to combat acute radiation syndrome - Knoxville News Sentinel
-
Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059 - Nature
-
Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice - Nature
-
Israeli Startup, US Gov’t Working On Radiation Poisoning Therapy - NoCamels
-
Radiation exposure drug maker says it is ramping up supply in Europe - WKTV
-
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - BioSpace
-
A Chernobyl 'suicide squad' of volunteers helped save Europe — here's their amazing true story - Business Insider
-
In HBO’s Chernobyl, firefighters battle the blaze at the Ukraine nuclear power plant shortly after the explosion at Reactor Number 4. The fire produced updrafts for nine days, sending radioactive material across parts of the western USSR and Europe. First resp - Television Academy
-
Sign of the times? US stocks up on Amgen's radiation sickness drug Nplate - Fierce Pharma
-
Pluri Readies Mass Production of Radiation Treatment Amid Global Nuclear Concerns - Stock Titan
-
US purchases $290 million of drug for use in radiological and nuclear emergencies - The Hill
-
Anti-Radiation Drugs Market to reach US$ 9.6 billion by 2031, expanding at a CAGR of 9.9%: TMR Report - Yahoo Finance
-
Chernobyl: What is radiation poisoning? How far did Chernobyl radiation go? - Daily Express
-
Ukraine gains access to Israeli anti-radiation drug amid nuclear threats - The New Voice of Ukraine
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.